VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

51 hedge funds and large institutions have $60M invested in Viridian Therapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+7
Holders Change %
+15.91%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
19
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$4.25M
2
Renaissance Technologies
Renaissance Technologies
New York
$855K
3
NI
Numeric Investors
Massachusetts
$565K
4
Deutsche Bank
Deutsche Bank
Germany
$634K
5
VF
Virtu Financial
New York
$541K

Top Sellers

1
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$0
2
SG Americas Securities
SG Americas Securities
New York
$0
3
Russell Investments Group
Russell Investments Group
United Kingdom
$0
4
Northern Trust
Northern Trust
Illinois
$1.42M
5
CS
Credit Suisse
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IWM
51
IHT Wealth Management
Illinois
$1K +$1K +10 New
UOTTAIMCU
52
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
– -$965K -7,031 Closed
SG Americas Securities
53
SG Americas Securities
New York
– -$250K -1,819 Closed
Russell Investments Group
54
Russell Investments Group
United Kingdom
– -$147K -1,072 Closed
CS
55
Credit Suisse
Switzerland
– -$95K -692 Closed
NFA
56
Nationwide Fund Advisors
Ohio
– -$64K -469 Closed
GT
57
Glenmede Trust
Pennsylvania
– -$16K -117 Closed
TRCT
58
Tower Research Capital (TRC)
New York
– -$14K -102 Closed
1 2
3